[
    {
        "file_name": "artaratherapeuticsinc_20200110_8-k_ex-10.5_11943350_ex-10.5_license agreement.pdf",
        "perturbation": [
            {
                "type": "Ambiguities - Ambiguous Legal Obligation",
                "original_text": "University represents:\n(a) The Program is being, and has been, conducted in accordance with all applicable local, state and federal laws, and regulations, including, but not limited to, the Federal Food, Drug and Cosmetic Act and the regulations of the FDA, International Conference on Harmonization Good Clinical Practices as adopted in the applicable FDA regulations (“GCP’s”), and the Form FDA 1572 Statements of Investigators.",
                "changed_text": "University represents:\n(a) The Program is generally conducted in accordance with applicable local, state and federal laws, and regulations, including, but not limited to, the Federal Food, Drug and Cosmetic Act and the regulations of the FDA, International Conference on Harmonization Good Clinical Practices as adopted in the applicable FDA regulations (“GCP’s”), and the Form FDA 1572 Statements of Investigators.",
                "explanation": "The original text requires strict compliance with all applicable laws and regulations. The modified text uses 'generally conducted,' which introduces ambiguity and suggests that deviations from strict compliance may occur. This weakens the obligation and makes enforcement more difficult.",
                "contradicted_law": "Federal Food, Drug, and Cosmetic Act and FDA regulations",
                "location": "Section 6.1"
            },
            {
                "type": "Ambiguities - Ambiguous Legal Obligation",
                "original_text": "ArTara will include the University of Iowa Research Foundation agreement number 2019- 068, a reference to “Richard Smith, MD, ArTara\nSponsored Research and License Agreement dated November 28, 2018” and purpose of payment with all payments. ArTara will add all applicable\nwire transfer fees to wire transfer payments.",
                "changed_text": "ArTara should try to include the University of Iowa Research Foundation agreement number 2019- 068, a reference to “Richard Smith, MD, ArTara\nSponsored Research and License Agreement dated November 28, 2018” and purpose of payment with most payments. ArTara might add applicable\nwire transfer fees to wire transfer payments.",
                "explanation": "The original text mandates including specific references and wire transfer fees. The modified text uses weaker language like 'should try' and 'might add,' making these actions optional and introducing ambiguity. This weakens the obligation to ensure proper tracking and allocation of funds, potentially violating accounting standards.",
                "contradicted_law": "Generally Accepted Accounting Principles (GAAP)",
                "location": "Section 3.6"
            },
            {
                "type": "Ambiguities - Ambiguous Legal Obligation",
                "original_text": "Insurance policies purchased to comply with this Article Seven will be kept in force for at least […***…] after the last sale of licensed\nProduct.",
                "changed_text": "Insurance policies purchased to comply with this Article Seven will be kept in force for a reasonable time after the last sale of licensed Product.",
                "explanation": "The original text specifies a clear duration for maintaining insurance policies after the last sale of a licensed product. The modified text uses 'a reasonable time,' which is vague and open to interpretation. This ambiguity weakens the obligation and creates uncertainty about the length of time insurance coverage is required, potentially violating contractual liability coverage needed for product liability under Iowa state law.",
                "contradicted_law": "Iowa Contract Law regarding reasonable expectations",
                "location": "Section 7.1(c)"
            }
        ]
    }
]